16 companies

Ascendis Pharma

Market Cap: US$10.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$168.17

7D

-2.2%

1Y

23.2%

Alnylam Pharmaceuticals

Market Cap: US$42.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$317.50

7D

-1.4%

1Y

24.6%

Exelixis

Market Cap: US$12.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$43.51

7D

-0.3%

1Y

96.4%

Insmed

Market Cap: US$18.4b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

New

INSM

US$96.14

7D

-1.5%

1Y

36.8%

BeOne Medicines

Market Cap: US$28.5b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$244.47

7D

-0.3%

1Y

69.1%

Eli Lilly

Market Cap: US$693.8b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

LLY

US$777.66

7D

0.2%

1Y

-16.6%

Vertex Pharmaceuticals

Market Cap: US$118.0b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

VRTX

US$466.36

7D

3.1%

1Y

-4.0%

Illumina

Market Cap: US$15.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ILMN

US$99.27

7D

1.1%

1Y

-6.9%

AbbVie

Market Cap: US$331.4b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

ABBV

US$189.77

7D

-0.1%

1Y

12.9%

Incyte

Market Cap: US$13.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$67.67

7D

-1.5%

1Y

11.5%

Neurocrine Biosciences

Market Cap: US$12.7b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

NBIX

US$128.74

7D

0.6%

1Y

-10.2%

Teva Pharmaceutical Industries

Market Cap: US$19.3b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

TEVA

US$16.63

7D

-0.06%

1Y

5.2%

Natera

Market Cap: US$21.7b

A diagnostics company, provides molecular testing services worldwide.

NTRA

US$158.48

7D

-1.4%

1Y

44.8%

Qiagen

Market Cap: US$10.3b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

QGEN

US$47.85

7D

-0.7%

1Y

16.1%

Tempus AI

Market Cap: US$10.1b

Operates as a healthcare technology company.

TEM

US$58.51

7D

-1.1%

1Y

67.2%

Viatris

Market Cap: US$10.8b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$9.26

7D

0.9%

1Y

-14.3%